Merck Sharp and Dohme LLC, (a subsidiary of Merck & Co. Inc.,
Rahway, New Jersey, USA)/ “A phase 2b Randomized, Double-Blind,
Placebo-Controlled Study to Evaluate the Efficacy and Safety of
MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic
Steatohepatitis.
Please contact us for more information or to learn if you are eligible to participate.
